Your browser doesn't support javascript.
loading
Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.
Khalifa, J; Tensaouti, F; Chaltiel, L; Lotterie, J-A; Catalaa, I; Sunyach, M P; Ibarrola, D; Noël, G; Truc, G; Walker, P; Magné, N; Charissoux, M; Ken, S; Peran, P; Berry, I; Moyal, E Cohen-Jonathan; Laprie, A.
Afiliação
  • Khalifa J; INSERM UMR 1214, TONIC (TOulouse NeuroImaging Centre), 31059, Toulouse, France. jonathan.khalifa@hotmail.fr.
  • Tensaouti F; Department of Radiation Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse - Oncopôle, 1 avenue Irène-Joliot Curie, 31100, Toulouse, France. jonathan.khalifa@hotmail.fr.
  • Chaltiel L; INSERM UMR 1214, TONIC (TOulouse NeuroImaging Centre), 31059, Toulouse, France.
  • Lotterie JA; Department of Biostatistics, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse - Oncopôle, 1 avenue Irène-Joliot Curie, 31100, Toulouse, France.
  • Catalaa I; INSERM UMR 1214, TONIC (TOulouse NeuroImaging Centre), 31059, Toulouse, France.
  • Sunyach MP; Department of Nuclear Medicine, CHU Rangueil, 1 Avenue du Professeur Jean Poulhès, 31400, Toulouse, France.
  • Ibarrola D; INSERM UMR 1214, TONIC (TOulouse NeuroImaging Centre), 31059, Toulouse, France.
  • Noël G; Department of Radiology, CHU Rangueil, 1 Avenue du Professeur Jean Poulhès, 31400, Toulouse, France.
  • Truc G; Department of Radiation Oncology, Centre Léon Bérard, 28 Rue Laënnec, 69373, Lyon, France.
  • Walker P; CERMEP - Imagerie du Vivant, Lyon, France.
  • Magné N; Department of Radiation Oncology, Centre Paul Strauss, EA 3430, University of Strasbourg, 3 rue de la Porte de l'Hôpital, 67065, Strasbourg, France.
  • Charissoux M; Department of Radiation Oncology, Centre Georges-François Leclerc, 1 rue Professeur Marion, 21079, Dijon, France.
  • Ken S; Laboratory of Electronics, Computer Science and Imaging (Le2I), UMR 6306 CNRS, University of Burgundy, Dijon, France.
  • Peran P; Department of Radiation Oncology, Institut de cancérologie Lucien-Neuwirth, 108 bis, avenue Albert-Raimond, 42271, Saint-Priest-en-Jarez, France.
  • Berry I; Department of Radiation Oncology, Institut du Cancer de Montpellier, 208 avenue des Apothicaires, parc Euromédecine, 34298, Montpellier cedex 5, France.
  • Moyal EC; INSERM UMR 1214, TONIC (TOulouse NeuroImaging Centre), 31059, Toulouse, France.
  • Laprie A; Department of Medical Physics, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse - Oncopôle, 1 avenue Irène-Joliot Curie, 31100, Toulouse, France.
Eur Radiol ; 26(11): 4194-4203, 2016 Nov.
Article em En | MEDLINE | ID: mdl-26843012
Assuntos
Palavras-chave
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Biomarcadores / Glioblastoma / Quimiorradioterapia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Radiol Assunto da revista: RADIOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Biomarcadores / Glioblastoma / Quimiorradioterapia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Radiol Assunto da revista: RADIOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França